Clinical Trials in Los Angeles

Showing 2781-2800 of 14,465 trials

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

NCT05277571

The purpose of the study is to investigate the safety and tolerability of single-ascending doses of UCB1381 (intravenous and subcutaneous) in healthy study participants and after repeat intravenous dosing in study participants with atopic dermatitis. Efficacy will be assessed following repeat intravenous dosing versus placebo in study participants with atopic dermatitis.

Atopic Dermatitis

UCB Biopharma SRL273 participantsStarted Mar 2022

Beverly Hills, California, United States • Glendale, California, United States • Los Angeles, California, United States +13 more locations

Active Not Recruiting< 1 mile

IN.PACT™ AV Access Post-Approval Study (PAS002)

NCT04543539

Long-term safety will be summarized

Arteriovenous FistulaArteriovenous Fistula StenosisArteriovenous Fistula Occlusion+1 more

Medtronic240 participantsStarted Nov 2020

Los Angeles, California, United States • Stanford, California, United States • New Haven, Connecticut, United States +17 more locations

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

IN.PACT™ AV Access Post-Approval Study (PAS002)

Find Trials by Condition in Los Angeles

Opioids and Social Support Enhanced Extinction Effects

Study of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular Injection

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Neurophysiologic Biomarkers in Rett Syndrome

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.

Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors

A Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in in Treatment-Naive Adults Living With HIV-1

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

Inappropriate Sinus Tachycardia Registry

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

Staphylococcus Aureus Network Adaptive Platform Trial